Beractant bulk supplier for pharma manufacturers

Beractant 25 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Intratracheal suspension

Available Strengths: 25 mg/mL

Reference Brands: Survanta(US & EU)

Beractant (Survanta) is a natural bovine lung surfactant used to treat and prevent Respiratory Distress Syndrome (RDS) in premature infants. Available in 25 mg/mL strength, it comes in 4 mL and 8 mL vials. FDA-approved and widely used in US and EU NICUs, it's essential in neonatal care.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Beractant, marketed as Survanta, is a bovine-derived pulmonary surfactant used for the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants. Each mL contains 25 mg of phospholipids, available in 4 mL (100 mg) and 8 mL (200 mg) single-use vials. Beractant is administered via intratracheal instillation to reduce surface tension in the lungs and improve neonatal respiratory function. Approved by the FDA and widely used in the US and EU, Survanta is a critical product in NICUs worldwide. Trusted by neonatologists, it is a top-choice surfactant for neonatal care and B2B sourcing.

Beractant — third party manufacturing & bulk supply

Beractant 25 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Beractant is supplied as Intratracheal suspension — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Beractant listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Beractant →

Back to Listing

Frequently Asked Questions

Beractant is listed as Intratracheal suspension in 25 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Beractant is referenced against Survanta(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.